Symposium

CAR-T Cells and the Transformation of Blood Cancer Treatments

Honoring Renier Brentjens, MD, PhD, Zelig Eshhar, PhD, Carl June, MD, Michel Sadelain, MD, PhD

The Warren Alpert Foundation and Harvard Medical School invite you to this annual scientific symposium, which will recognize four scientists for pioneering applications of chimeric antigen receptors to engineer T cells for adoptive immunotherapy of cancer and autoimmunity.

Thursday, Oct. 10
2 p.m.
Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
RSVP  here.

Opening Remarks
George Q. Daley, MD, PhD
Dean of the Faculty of Medicine, Harvard University,
Caroline Shields Walker Professor of Medicine

Marcela Maus, MD, PhD
Paula O’Keefe Endowed Chair and Director, Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center
Professor of Medicine, Harvard Medical School

Award Lectures
Renier Brentjens, MD, PhD
Katherine Anne Gioia Endowed Chair in Cancer Medicine and Deputy Director at Roswell Park Comprehensive Cancer Center

Carl June, MD
Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania Perelman School of Medicine

Michel Sadelain, MD, PhD
Stephen and Barbara Friedman Chair and Founding Director of the Center for Cell Engineering at Memorial Sloan Kettering Cancer Center

Invited Speakers
Alexander Marson, MD, PhD
Director of the Gladstone-UCSF Institute of Genomic Immunology and Professor of Medicine and Microbiology and Immunology at University of California, San Francisco

Christine Brown, PhD
Heritage Provider Network Professor in Immunotherapy and Deputy Director, T Cell Therapeutics Research Laboratory at City of Hope

Open to the Public. Seating is on a first come, first served basis.